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Abstract: B a c k g rou nd: Recoarctation (reCoA) of the aorta is a  common complication aft er the 
Norwood procedure. Untreated, it can lead to failure of the systemic ventricle and death. Th e main goal 
of the study is to defi ne risk factors of reCoA aft er the Norwood procedure in hypoplastic left  heart 
syndrome (HLHS).
Met hod s: We retrospectively analyzed the pre-, intra- and postoperative data of 96 successive patients 
who underwent the Norwood procedure between 2007 and 2011. In case of reCoA balloon angioplasty 
was performed. We analyzed and compared the data of the patients with reCoA and without reCoA using 
the StatSoft  STATISTICA™ 10 soft ware.
Re su lt s: ReCoA was noted in 23 patients (33.3%). Th is complication was diagnosed 95.1 days (49–156 
days) on the average aft er the Norwood procedure. Balloon angioplasty successfully allowed for decreasing 
the mean gradient across the site of the narrowing from the average 27.5 mmHg to the average 9.7 mmHg 
(p = 0.008) and enlarged the neo-isthmus by the average of 2 mm (p <0.05). Th e risks factors seemed to be 
the diameter of the ascending aorta OR = 7.82 (p = 0.001), atresia of the mitral valve OR = 7.00 (p = 0.003) 
and atresia of the aortic valve — OR = 6.22 (p = 0.002).
C onclu sion : Balloon angioplasty seems to be an eff ective intervention in case of reCoA. A low diameter 
of the native ascending aorta (≤3mm) and the presence of atresia of the mitral and/or aortic valve should 
intensify the vigilance of a cardiologist in the search for signs of reCoA of the aorta.
Key words: hypoplastic left  heart syndrom, coarctation, angioplasty, risk analysis.
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Introduction 
Th e Norwood procedure (NP) is the fi rst stage of the surgical treatment of 
hypoplastic left  heart syndrome (HLHS) [1]. Th e procedure is associated with 
numerous complications that may lead to death in the late postoperative period. 
One of the most common and most serious complications following the Norwood 
procedure is recoarctation of the aorta (reCoA), which occurs in 11 to 37% [2, 3] of 
children. Th e prolonged high pressure gradient across the region of the aortic isthmus 
may contribute to deterioration of the function of the right, single ventricle and to 
death [4] (Fig. 1). Risk factors of the neo-aorta recoarctation are not clearly defi ned. 
Such factors are suspected of aff ecting the phenomenon as the surgical technique, 
remnants of ductus arteriosus tissue and remnants of ductus tissue present in the 
pulmonary homograft  employed in aorta reconstruction [4–7].
Fig. 1. Th e fi gure presents the mean heart function (systolic function in %) in patients aft er the Norwood 
procedure, in patients with recoarctation of the aorta (reCoA) and in patients aft er the hemi-Fontan 
operation (hemi-F) as seen in echocardiography. 
Th e objective of the paper is the assessment of risk factors involved in reCoA aft er 
the Norwood procedure in children with HLHS. We hope the results will allow for 
defi ning a group with an increased risk of reCoA development.
Methods 
Th e study is a retrospective analysis. All the data were obtained from medical records. 
HLHS was diagnosed based on echocardiography that evaluated the morphology of 
the mitral and aortic valves (obstruction or stenosis), diameter of the ascending aorta, 
diameter of the aortic arch and presence of atrial level restrictions. Intraoperative 
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data were also analyzed (the technique of aorta reconstruction, total time of 
cardiopulmonary bypass, time of circulatory arrest and age at the Norwood operation), 
as well as postoperative data (duration of ICU hospitalization, development of reCoA 
and early and late postoperative mortality).
ReCoA of the aorta was detected in diagnostic echocardiography performed 
when the condition of the child deteriorated or else while carrying out a  routine 
cardiological follow-up. Th e suspicion of reCoA was invasively confi rmed by heart 
catheterization.
Th e analysis included the parameters determined during the above procedure (the 
pressure gradient across the coarctation, diameter of the coarctation, systolic pressure 
in the ascending aorta, systolic and diastolic pressure in the descending aorta prior 
to and aft er balloon angioplasty). We took into consideration the age of the patients 
at the time of heart catheterization and the time lapse from the Norwood procedure.
Norwood procedure
Th e NP was performed using deep hypothermia and circulatory arrest. In patients 
with the ascending aorta above 3.5 mm, the aortic cannula was inserted close to the 
origin of the brachiocephalic trunk. In patients with smaller ascending aorta, the 
cannula was placed in the middle aspect of the ductus arteriosus and relocated to the 
ascending aorta aft er the reconstruction of the aorta. Aft er initiating cardiopulmonary 
bypass, rapid cooling was started and maintained for at least 15 min, which usually 
led to establishing the temperatures as low as 14°C. During the cooling phase, the 
proximal aspect of the pulmonary trunk was transected and the distal part was fi xed 
to Right Ventricle-Pulmonary Artery shunt (RVPAs). Myocardial protection was 
achieved with the single-dose crystalloid cardioplegia 15 ml/kg infused to ascendent 
aorta. Th e technique of reconstruction of the aorta consist to reconstruct the aorta 
with a pulmonary homograft  patch in 91% of cases. Th e aortic arch was incised along 
its minor curvature, beginning at the open aortic isthmus and extending proximally 
down the ascending aorta. Th e residual ductal tissue was excised from the descending 
thoracic aorta. In the last 9% the pulmonary truck was connected directly to aortic 
arch. Atrial septectomy was performed through the cannulation site, the CPB was 
reinstituted. Proximal part of RVPAs was fi xed to right ventricule about 1 cm under 
the pulmonary (neoaortic) valve.
Data analysis 
To describe the investigated population, such mathematic calculations were employed 
as the percentage of occurrence of the phenomena that were important in the 
context of the study, arithmetic mean, median, range and standard deviation values. 
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Th e statistical analysis was based on the following tests: chi-square, T-student, 
Mann-Whitney, Fisher and logical regression test, with the signifi cance level assumed 
to be p <0.05. To meet the above objectives, the StatSoft  STATISTICA™ 10 (Statsoft  
Inc., Tulsa, OK, USA) soft ware was used.
Material 
In the years 2008–2010, 96 children were subjected to the Norwood operation in the 
Krakow Department of Pediatric Cardiac Surgery as the fi rst stage of the surgical 
treatment of hypoplastic left  heart syndrome (Table 1 and 2).
Table 1. Characterization of the population qualifi ed for the Norwood procedure.
Variable N = 96 (100%)
Age at the Norwood procedure 
(days)
<7 days  3 (3%)
7–14 days 49 (51%)
>14 days 44 (46%)
Gender 
boys 67 (70%)
girls 29 (30%)
Diameter of ascending aorta 
(mm)
<2 mm  5 
2–3 mm 33
>3 mm 50
HLHS morphology 
AA/MA 18 (19%)
AA/MS 34 (35%)
AS/MA  2 (2%)
AS/MS 37 (38%)
undefi ned  5 (5%)
Table 2. General characterization of the Norwood population and operative data.
Mean Median
Birth body mass (g) 3340.00 ± 504.10 3300.0
Time of cardiopulmonary bypass (min) 141.56 ± 54.92  128.0
Time of circulatory arrest (min) 50.76 ± 24.38   46.5
Diameter of ascending aorta (mm) 3.76 ± 1.71    3.3
Diameter of aortic arch (mm) 5.06 ± 1.00    5.0
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We excluded from the study group the children who died before the second stage 
of the treatment (the hemi-Fontan or Glenn procedure) in whom reCoA was not 
diagnosed in imaging studies or on autopsy (n = 20) and such patients whose further 
treatment was continued in other cardiac surgical centers (n = 7).
Th e fi nal analysis included data pertaining to 69 children. Seventy-four percent of 
them (n = 51) were boys, 26% (n = 18) — girls. Th e mean birth body mass was 3340 g 
(Me 3340 g, range: 2180–4450 g). Th e mean age at operation was 14.4 days (Me 14 days, 
range: 6–33 days). Th e most common HLHS morphology was aortic valve atresia with 
mitral valve stenosis (42.6%). On the other hand, the least frequent morphology was 
aortic valve stenosis with mitral valve atresia (3%). Th e perioperative mortality rate 
was 9.7% (n = 9), while mortality in the period between the fi rst and second stage of 
HLHS correction was 21.8% (n = 19). ReCoA was detected in 23 children (33.3%).
Th e initial group was divided into two subgroups: Group A that included children 
with diagnosed reCoA in whom balloon angioplasty was performed, and Group B 
where reCoA did not occur.
Results 
Comparison of Group A and B (Table 3).
Table 3. Comparison of group with reCoA (reCoA+) and without reCoA (reCoA–).
All operated 
patient
(n = 69)
Patient with 
ReCoA
(n = 23)
Patient without 
ReCoA
(n = 46)
p >0.05 OR(95% CI)
Age (days) 14.40Me = 14
13.58
Me = 14
14.77
Me = 14 0.7 0.74
Body mass (g) 3340 Me = 3330
3360 
Me = 3410
3320 
Me = 3310 0.59 1.19
Gender (boys) 50.00 15 (68%) 35  (78%) 0.56 1.48
Ascending aorta (mm)  3.76Me = 3.25
2.93
Me = 2.50
4.17 
Me = 3.50 0.001 0.55
Aortic arch diameter (mm)  5.06 Me = 5.00
5.11
Me = 5.00
5.04 
Me = 5.00 0.715 1.08
Atrial level restrictions 33 12 (55%) 21 (46%) 0.606 1.42
Type of surgery:
Complete reconstruction 63 22 (91%) 41 (89%) 0.656
Suturing to pulmonary trunk  6 1 (9%)  5 (11%) 0.656
Aortic valve atresia 37 18 (78%) 19 (41%) 0.002 6.22
Mitral valve atresia 15 10 (43%)  5 (11%) 0.003 7.00
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No signifi cant diff erence was noted between Group A and Group B with respect 
to the birth body mass, age at the Norwood procedure, diameter of the native aortic 
arch (Group A — 5.11 mm, Group B — 5.04 mm), type of the performed procedure 
and time of circulatory arrest.
Signifi cant diff erences were seen in the diameter of the native ascending aorta, 
which in Group A had the mean value of 2.93 ± 1.40  mm and in Group  B — 
4.17 ± 1.72 mm (p = 0.001). Th e ascending aorta diameter equal to or lower than 
2.5  mm was seen in 50% of the reCoA group neonates and only in 17% newborns 
in the non-reCoA group. Th e highest probability of reCoA development was noted 
in case of the ascending aorta with the diameter between 2 and 3 mm (Fig. 2 and 
Table 4). In addition, we observed that in 72.7% of children diagnosed with reCoA, 
the diameter of the ascending aorta was below 3 mm (Table 4). Th us, the entire 
group of the patients was divided into two subgroups with respect to the length of 
the ascending aorta diameter: <3 mm and ≥3 mm. Th e analysis demonstrated that 
the chance of reCoA occurring in the group of patients with the ascending aorta 
diameter equal to or lower than 2.9 mm was almost eightfold higher — OR = 7.82 
(95% CI 2.45–29.2) (p = 0.001).
Fig. 2. Th e graph presents the incidence of reCoA depending on the ascending aorta diameter. At the 
top, marked with circles — patients with reCoA, at the bottom — patients without reCoA.
As compared to Group B, the Group A children more oft en presented with aortic 
valve atresia — 78% and 41%, respectively (p = 0.002) and mitral valve atresia — 43% 
and 11%, respectively (p = 0.003). In case of HLHS with aortic valve atresia, the risk of 
reCoA development was more than six-fold higher — OR = 6.22 (95% CI 1.69–29.4) 
(p = 0.002). A similar situation was noted in case of mitral valve atresia, where the risk 
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of reCoA was seven-fold higher as compared to children without mitral valve atresia 
— OR = 7.00 (95% CI 1.76–32.1) (p = 0.003).
Aortic recoarctation was detected in 23 patients (33.3%). In one patient, the 
diagnosis was established postmortem during autopsy. Th e complication was suspected 
as a result of echocardiography and physical examinations performed during scheduled 
follow-up visits (every 2 and subsequently every 4 weeks) or when the condition of 
the child worsened and the patient reported to the emergency department. Th e fi nal 
diagnosis of reCoA was established at the mean time of 91.95 ± 30.14 days aft er the 
Norwood procedure (49–156 days). Based on echocardiography results and general 
condition of the children, all the patients were qualifi ed for urgent or scheduled heart 
catheterization with a  simultaneous attempt at dilating the stenotic site by balloon 
angioplasty. Th e procedure allowed for decreasing the mean pressure gradient across 
the stenotic site from the mean value of 31.6 ± 13.1 mmHg to the mean value 
amounting to 11.3 ± 9.6 mmHg (p = 0.008) and for dilating the neo-isthmus by the 
mean value of 1.93 ± 0.98 mm (p <0.05) (0.7–4.5 mm). One patient died on the third 
day aft er catheterization due to systemic ventricular insuffi  ciency and heart rhythm 
abnormalities. In one patient, because of ineff ective BAA, a  stent was implanted in 
the aortic isthmus. Th e patient required repeated heart catheterization procedures 
in order to dilate the stent. In three patients (13%) aft er BAA, recoarctation of the 
aorta was diagnosed prior to the second stage of the treatment and they required 
another isthmus aortoplasty. In one patient aft er the second stage of the treatment, 
recoarctation of the aorta was diagnosed; BAA was employed in the child 112 days 
Table 4. Number of patients with reCoA (reCoA+) and without reCoA (reCoA–) in particular ranges of 
ascending aorta diameter values.
Ascending aorta 
diameter
(mm)
reCoA–
(n)
reCoA+
(n)
Cumulated number 
of events of reCoA
(%)
1.9–2.4  8 9  39.1
2.5–2.9  4 8  73.9
3.0–3.4  7 2  82.6
3.5–3.9  7 0  82.6
4.0–4.4  2 0  82.6
4.5–4.9  3 0  82.6
5.0–5.4  2 2  91.3
  ≥5.5 13 2 100.0
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after first intervention. None of the patients required surgical correction of the 
stenotic segment.
Discussion 
Recoarctation of the aorta is a  common complication aft er the Norwood operation. 
When undiagnosed and untreated appropriately early, it leads to impairment of the 
systemic function of the right ventricle and to death due to circulatory insuffi  ciency.
Despite modifi cations of surgical techniques, modern equipment and increasing 
experience of centers providing surgical treatment of single ventricle hearts, reCoA 
continues to be a serious, life-threatening complication aft er the Norwood procedure. 
Based on postmortem examinations, Van Praagh determined the most common 
causes of death aft er the Norwood operation. Approximately 14% of children with 
HLHS die due to reCoA. Th is is the fourth cause of all deaths in children with the 
above condition [8].
In our center, the prevalence of the complication was 32.3%. However, the value is 
within the range of values published as a result of studies performed in other centers.
It seems that one of the signifi cant reCoA risk factors are the remnants of the 
ductus arteriosus tissue in the aortic isthmus region. In postmortem examinations, 
residual ductal tissue in the aortic wall was noted in 4 out of 5 patients with reCoA [9].
Burkhart et al. presented their therapeutic results achieved following the 
employment of a novel surgical technique consisting in total resection of the ductal 
tissue when reconstructing the aorta in the course of the Norwood procedure. 
Th e “alternating” method allowed for a  signifi cant reduction of reCoA occurrence 
from 46% to 0% [10].
Some authors suggest the eff ect of the type of material employed while recon-
structing the aorta on the prevalence of neo-aorta coarctation. Th e theory has not been 
confi rmed by the most recent studies [11]. Th e results of surgical treatment employing 
a  femoral vein homograft  published by Jonas point to a  better survival rates in late 
follow-up as compared to standard materials and techniques. Nevertheless, the eff ect 
of the method on restricting the occurrence of reCoA has not been proven  [12]. In 
our center, all the patients in whom material for aortic reconstruction was employed 
were operated on using a pulmonary artery homograft .
In 2013, Cleuziou et al. published a report where the percentage of reCoA in the 
study population amounted to 13.4% [13]. Nevertheless, no risk factor associated with 
the complication was determined. Our study demonstrated signifi cant diff erences in 
the two groups with and without reCoA; the said diff erences included the ascending 
aorta diameter, mitral and aortic valve atresia. As it follows from the analysis, the 
chance of reCoA occurrence in the group of patients with the ascending aorta 
diameter below 4 mm is almost eight-fold higher as compared to the other patients. 
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In case of the HLHS variant with aortic valve atresia, the risk of the complication 
is more than six-fold higher. Th e same situation was noted in case of mitral valve 
atresia, where the risk of reCoA is seven-fold higher as compared to the HLHS 
variants without mitral valve atresia.
Under hemodynamic conditions of hypoplastic left heart syndrome after the 
Norwood procedure, the stricture of the outfl ow tract from the right ventricle may 
permanently impair its function [4]. For this reason, an early diagnosis and treatment 
of recoarctation of the neo-aorta is of an utmost importance for the future of the 
child. In all the patients we analyzed, the preliminary diagnosis of reCoA was 
established based on echocardiography. Our suspicion was triggered by dysfunction 
of the right ventricle, pressure gradient across the aorta in echocardiogrphy above 
20 mmHg while the systemic ventricular function was good or by a visible narrowing 
of the neo-aorta. In each case, the diagnosis was confi rmed by heart catheterization. 
According to the European Cardiology Society, the diagnosis of hemodynamically 
significant stenosis is warranted if the pressure gradient across the stenotic site 
measured in the course of heart catheterization is at least 20 mmHg [14]. However, 
an early diagnosis of the complication seems to be a  challenge. As it follows from 
the preliminary observations in the present group, some patients developed signs 
of reCoA over several months, while in others signifi cant recoarctation appeared 
suddenly, without any prior symptoms. 
The standard in treating reCoA used by many center is balloon angioplasty 
performed during heart catheterization [15–18]. Th e procedure turned out to be 
eff ective in 74% of the patients who did not require repeated interventions.
Conclusions 
1. In the postoperative course following the first stage of surgical treatment of 
hypoplastic left  heart syndrome, the risk factors associated with recoarctation of 
the aorta include: ascending aorta diameter below 2.5 mm and aortic valve atresia 
and/or mitral valve atresia detected at echocardiography prior to qualifi cation for 
the Norwood procedure.
2. Balloon angioplasty seems to be an eff ective mode of reCoA treatment that is 
associated with a low risk of complications and does not interfere with the strategy 
of routine three-stage treatment of hypoplastic left  heart syndrome.
Based on the results of the present study, one may defi ne a group with a high risk 
of reCoA occurrence aft er the fi rst stage of HLHS treatment. Subjecting these patients 
to intensive care would allow for an early detection of recoarctation of the aorta and 
for preventing the development of life-threatening complications. 
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Limitations
Due to the low number of subjects in the investigated population, the results of 
the present study require confi rming by other analyses based on more numerous 
databases. 
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